top of page

OGIVRI™ LYOPHILIZED POWDER FOR INJECTION 440MG PER VIAL

Product details

Registration number: SIN15850P

Classification: Prescription Only

Active ingredients: (Powder) Trastuzumab

Strength: 440 mg/vial

Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Route: INTRAVENOUS

Registrant: CEDAR PHARMACEUTICALS PTE. LTD.

ATC code: L01XC03

HSA approval date: 4 November 2019

Manufacturer(s): Biocon Biologics Limited (Powder and Diluent)

Manufacturing country/countries: INDIA

What are the HSA registration number and classification for OGIVRI™ LYOPHILIZED POWDER FOR INJECTION 440MG PER VIAL?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN15850P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for OGIVRI™ LYOPHILIZED POWDER FOR INJECTION 440MG PER VIAL?

According to the HSA dataset updated 7 August 2026:

Active ingredients: (Powder) Trastuzumab

Strength: 440 mg/vial

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for OGIVRI™ LYOPHILIZED POWDER FOR INJECTION 440MG PER VIAL?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Route: INTRAVENOUS

Source for this answer

Who is the recorded registrant for OGIVRI™ LYOPHILIZED POWDER FOR INJECTION 440MG PER VIAL?

According to the HSA dataset updated 7 August 2026:

Registrant: CEDAR PHARMACEUTICALS PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for OGIVRI™ LYOPHILIZED POWDER FOR INJECTION 440MG PER VIAL?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): Biocon Biologics Limited (Powder and Diluent)

Manufacturing country/countries: INDIA

Source for this answer

Where can I look up OGIVRI™ LYOPHILIZED POWDER FOR INJECTION 440MG PER VIAL in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN15850P or the exact product name OGIVRI™ LYOPHILIZED POWDER FOR INJECTION 440MG PER VIAL. The general register link does not preselect this product.

Source for this answer

What are the source dates for this OGIVRI™ LYOPHILIZED POWDER FOR INJECTION 440MG PER VIAL record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this OGIVRI™ LYOPHILIZED POWDER FOR INJECTION 440MG PER VIAL record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN15850P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page